Here's our initial take on Vertex Pharmaceuticals' (NASDAQ: VRTX) fourth-quarter financial report. Vertex reported solid fourth-quarter numbers throughout its business. While the company's ...

Vertex reported solid fourth-quarter numbers throughout its business. While the company's earnings per share came in slightly shy of expectations, top-line revenue growth was a significant beat.

Vertex Pharmaceuticals beat expectations for revenue but missed on earnings. The company has two recent FDA approvals and several treatments in late-stage trials. The core CF treatments make up ...

The company owns nearly 5,000km of pipelines and 7.6M barrels of oil storage, with the Keystone Pipeline system being its main asset. Despite tariff concerns, South Bow's shares remain ...

Novartis said this morning that its pipeline includes more than 30 high-value projects that allow it to achieve sales growth of 6% or more between out to 2029, a point higher than its earlier ...

One example is the competing philosophies of the Bow Tie and the Diamond. This is an area where the theory and best practice are in complete alignment. However, some senior managers high up in the ...

Tesla is facing dramatic sales drops across Europe as the electric car maker faces backlash over Elon Musk’s active role in the Trump administration. Musk, whose Department of Government ...

Investing.com - U.S. retail sales contracted by more than anticipated in January, as a cold weather snap and natural disasters hit spending activity that has been largely bolstered by a resilient ...

Goldman's results, U.S. retail sales, County Garden - what's moving markets By Investing.com - Oct 17, 2023 12 Investing.com --Goldman Sachs releases its latest quarterly results in difficult ...